Aarti Pharmalabs Ltd Financial Statement - Aarti Pharmalabs Ltd Balance Sheet | Research 360 by Motilal Oswal
16:05 Apr 12

Aarti Pharmalabs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
449.65
+2.85 (+0.64%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Aarti Pharmalabs Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
449.65
+2.85 (+0.64%)
16:05 Apr 12
Quality
image/svg+xml

86/100
High Financial Strength

Valuation
image/svg+xml

49/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

6

Weakness

6

Opportunity

0

Threats

1

12.41 %

ROE %

8.67 %

ROA %

21.35

EPS

171.97

BVPS

9.94 %

Net Profit Margin

Mar 2022 Mar 2023 TTM 2023
Net Sales
1199.94 1945.23 1831.91
Operating Expenses +
993 1603.19 1483.37
Raw Material
774.16 1295.12 1080.9
Increase Decrease in Cost
-49.05 -125.36 -18.3
Other Manufacturing Expense
154.59 235.71 0
Employee Cost
85.2 129.69 134.24
Miscellaneous Expenses
353.94 629.67 286.53
Operating Profit
206.94 342.04 348.54
Other Income
2.51 2.32 3.59
Depreciation
42.12 62.54 70.06
Interest
11.96 21.05 18.48
Profit before tax and exceptio..
155.38 260.77 263.59
Exceptional Items
0 0 0
PBT
155.38 260.77 263.59
Provision for Taxation
33.13 67.28 69.08
Net Profit
122.25 193.49 194.52
NET Profit after MI
122.25 193.49 194.52
EPS
13.49 21.35 21.47
Operating Profit Margin (%)
17.25 17.58 19.03
Net Profit Margin (%)
10.19 9.95 10.62

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 46.50 46.50 46.30 46.00 46.00
FII 8.30 8.20 8.40 7.40 7.70
MF 2.70 2.00 2.70 2.70 5.10
Public 35.20 35.40 34.70 35.90 32.60
Others 7.30 7.90 7.90 8.00 8.60
Shareholder Shares Holding %

Download Our App On: